Upbeat on Duopharma Biotech with stock closing near 52-week high
Duopharma Biotech’s cumulative nine months of the financial year 2019 (9MFY19) earnings grew 30% year-on-year (yoy) to RM43.2 mil
Your business advantage
Duopharma Biotech’s cumulative nine months of the financial year 2019 (9MFY19) earnings grew 30% year-on-year (yoy) to RM43.2 mil
With over 120,000 retail points, the Touch ‘n Go eWallet continues to expand its presence across all lifestyle touchpoints